NasdaqGS - Delayed Quote USD
Humacyte, Inc. (HUMA)
1.4700
+0.1000
+(7.30%)
At close: April 23 at 4:00:02 PM EDT
1.5000
+0.03
+(2.04%)
Pre-Market: 8:08:12 AM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 114,187 | 9 |
Sales | 3,000,000 | 2 |
Net Shares Purchased (Sold) | -2,885,813 | 11 |
Total Insider Shares Held | 32.96M | -- |
% Net Shares Purchased (Sold) | -8.10% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
SCHEESSELE WILLIAM JOHN Officer | Purchase at price 1.54 per share. | Direct | 9,999 | Apr 14, 2025 |
SANDER DALE A Chief Financial Officer | Purchase at price 1.53 per share. | Indirect | 30,600 | Apr 10, 2025 |
PARIKH SHAMIK J Officer | Purchase at price 1.55 per share. | Direct | 11,625 | Apr 10, 2025 |
SEBELIUS KATHLEEN G Director | Purchase at price 1.32 per share. | Direct | 66,000 | Apr 8, 2025 |
GREEN CHARLES BRUCE Director | Purchase at price 1.29 per share. | Direct | 7,740 | Apr 8, 2025 |
CONSTANTINO MICHAEL T Director | Purchase at price 1.26 per share. | Direct | 20,160 | Apr 7, 2025 |
CONSTANTINO MICHAEL T Director | Purchase at price 4.39 per share. | Direct | 20,181 | Dec 4, 2024 |
DOUGAN BRADY W Director | Sale at price 4.34 - 4.44 per share. | Indirect | 6,606,799 | Nov 20, 2024 |
NIKLASON LAURA E Chief Executive Officer | Sale at price 4.34 - 4.44 per share. | Indirect | 6,606,799 | Nov 20, 2024 |
DOUGAN BRADY W Director | Purchase at price 4.44 per share. | Indirect | 7,979 | Nov 19, 2024 |
NIKLASON LAURA E Chief Executive Officer | Purchase at price 4.44 per share. | Direct | 7,979 | Nov 19, 2024 |
GREEN CHARLES BRUCE Director | Conversion of Exercise of derivative security at price 4.09 per share. | Direct | 4,908 | Sep 13, 2024 |
DOUGAN BRADY W Director | Sale at price 5.23 - 5.42 per share. | Indirect | 2,364,521 | Sep 10, 2024 |
SEBELIUS KATHLEEN G Director | Sale at price 5.39 - 5.41 per share. | Direct | 28,004 | Sep 10, 2024 |
SEBELIUS KATHLEEN G Director | Conversion of Exercise of derivative security at price 3.35 - 4.34 per share. | Direct | 27,926 | Sep 10, 2024 |
NIKLASON LAURA E Chief Executive Officer | Sale at price 5.23 - 5.42 per share. | Indirect | 2,364,521 | Sep 10, 2024 |
DOUGAN BRADY W Director | Sale at price 6.35 - 6.71 per share. | Indirect | 5,724,139 | Aug 29, 2024 |
DOUGAN BRADY W Director | Purchase at price 6.54 per share. | Indirect | 7,998 | Aug 29, 2024 |
NIKLASON LAURA E Chief Executive Officer | Sale at price 6.35 - 6.71 per share. | Indirect | 5,724,139 | Aug 29, 2024 |
NIKLASON LAURA E Chief Executive Officer | Purchase at price 6.54 per share. | Direct | 7,998 | Aug 29, 2024 |
SANDER DALE A Chief Financial Officer | Sale at price 6.68 per share. | Direct | 263,119 | Aug 27, 2024 |
SANDER DALE A Chief Financial Officer | Conversion of Exercise of derivative security at price 2.56 per share. | Direct | 100,836 | Aug 27, 2024 |
CONSTANTINO MICHAEL T Director | Purchase at price 6.29 per share. | Direct | 19,494 | Aug 15, 2024 |
SEBELIUS KATHLEEN G Director | Conversion of Exercise of derivative security at price 2.56 per share. | Direct | 100,836 | Jun 14, 2024 |
DOUGAN BRADY W Director | Sale at price 7.02 - 7.30 per share. | Indirect | 4,520,024 | Jun 12, 2024 |
NIKLASON LAURA E Chief Executive Officer | Sale at price 7.02 - 7.30 per share. | Indirect | 4,520,024 | Jun 12, 2024 |
DOUGAN BRADY W Director | Sale at price 7.28 - 8.93 per share. | Indirect | 7,832,200 | Jun 4, 2024 |
DOUGAN BRADY W Director | Purchase at price 6.35 per share. | Indirect | 14,999 | Jun 4, 2024 |
NIKLASON LAURA E Chief Executive Officer | Sale at price 7.28 - 8.93 per share. | Indirect | 7,832,200 | Jun 4, 2024 |
NIKLASON LAURA E Chief Executive Officer | Purchase at price 6.35 per share. | Direct | 14,999 | Jun 4, 2024 |
DOUGAN BRADY W Director | Purchase at price 7.37 per share. | Indirect | 15,108 | Jun 3, 2024 |
NIKLASON LAURA E Chief Executive Officer | Purchase at price 7.37 per share. | Direct | 15,108 | Jun 3, 2024 |
PRICHARD HEATHER LEDBETTER Chief Operating Officer | Sale at price 7.48 - 8.36 per share. | Direct | 1,556,534 | May 31, 2024 |
PRICHARD HEATHER LEDBETTER Chief Operating Officer | Conversion of Exercise of derivative security at price 2.56 - 3.07 per share. | Direct | 349,544 | May 30, 2024 |
WALLACE MAX N Director | Purchase at price 6.21 - 6.29 per share. | Indirect | 50,030 | May 20, 2024 |
GREEN CHARLES BRUCE Director | Conversion of Exercise of derivative security at price 4.09 per share. | Direct | 2,454 | May 20, 2024 |
GREEN CHARLES BRUCE Director | Conversion of Exercise of derivative security at price 4.09 per share. | Direct | 2,454 | May 17, 2024 |
BINDER GORDON M Director | Purchase at price 6.57 - 6.78 per share. | Indirect | 667,500 | May 15, 2024 |
WALLACE MAX N Director | Conversion of Exercise of derivative security at price 1.19 per share. | Direct | 7,811 | Nov 21, 2023 |
DOUGAN BRADY W Director | Conversion of Exercise of derivative security at price 1.19 per share. | Indirect | 136,160 | Oct 10, 2023 |
NIKLASON LAURA E Chief Executive Officer | Conversion of Exercise of derivative security at price 1.19 per share. | Direct | 136,160 | Oct 10, 2023 |
DOUGAN BRADY W Director | Sale at price 3.54 per share. | Indirect | 7,080,000 | Sep 14, 2023 |
NIKLASON LAURA E Chief Executive Officer | Sale at price 3.54 per share. | Indirect | 7,080,000 | Sep 14, 2023 |
DOUGAN BRADY W Director | Sale at price 3.39 - 3.68 per share. | Indirect | 6,378,837 | Aug 21, 2023 |
NIKLASON LAURA E Chief Executive Officer | Sale at price 3.39 - 3.68 per share. | Indirect | 6,378,837 | Aug 21, 2023 |
AYABUDGE, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.39 - 3.68 per share. | Direct | 6,378,837 | Aug 21, 2023 |
DOUGAN BRADY W Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.12 per share. | Indirect | 1,558,750 | Jun 15, 2023 |
NIKLASON LAURA E Chief Executive Officer | Sale at price 3.12 per share. | Indirect | 1,558,750 | Jun 15, 2023 |
AYABUDGE, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.12 per share. | Direct | 1,558,750 | Jun 15, 2023 |
DOUGAN BRADY W Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.65 per share. | Indirect | 17,793,750 | Jun 13, 2023 |
Related Tickers
MREO Mereo BioPharma Group plc
2.5600
+2.40%
XERS Xeris Biopharma Holdings, Inc.
4.1300
+0.73%
CAPR Capricor Therapeutics, Inc.
13.15
-5.33%
IOVA Iovance Biotherapeutics, Inc.
3.1900
-0.62%
SANA Sana Biotechnology, Inc.
1.7100
-1.16%
RCKT Rocket Pharmaceuticals, Inc.
7.14
+2.44%
IBRX ImmunityBio, Inc.
2.6900
0.00%
MIST Milestone Pharmaceuticals Inc.
1.1600
+9.43%
GERN Geron Corporation
1.3900
-1.42%
VINC Vincerx Pharma, Inc. Common Stock
0.2750
+7.34%